600 related articles for article (PubMed ID: 930589)
1. Two cases of nevoid basal cell carcinoma syndrome.
Satoh M; Fukazawa H; Yagawa K; Endo H; Suzuki A
Acta Pathol Jpn; 1977 Sep; 27(5):713-27. PubMed ID: 930589
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma.
Gause BL; Sharfman WH; Janik JE; Curti BD; Steis RG; Urba WJ; Smith JW; Alvord WG; Longo DL
Cancer Invest; 1998; 16(6):374-80. PubMed ID: 9679527
[TBL] [Abstract][Full Text] [Related]
3. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro.
Auzenne E; Leroux ME; Hu M; Pollock RE; Feig B; Klostergaard J
Melanoma Res; 1998 Jun; 8(3):227-39. PubMed ID: 9664144
[TBL] [Abstract][Full Text] [Related]
5. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
Ladekarl M
APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
[TBL] [Abstract][Full Text] [Related]
6. The expression of C-myb in human metastatic melanoma cell lines and specimens.
Walker MJ; Silliman E; Dayton MA; Lang JC
Anticancer Res; 1998; 18(2A):1129-35. PubMed ID: 9615777
[TBL] [Abstract][Full Text] [Related]
7. Lower frequency of sister chromatid exchanges and altered frequency of HLA B-region alleles among individuals with sporadic dysplastic nevi.
Illeni MT; Rovini D; Di Lernia M; Cascinelli N; Ghidoni A
Int J Biol Markers; 1997; 12(3):118-24. PubMed ID: 9479594
[TBL] [Abstract][Full Text] [Related]
8. Amino acids and peptides. XXX. Preparation of Arg-Gly-Asp (RGD) hybrids with poly(ethylene glycol) analogs and their antimetastatic effect.
Maeda M; Izuno Y; Kawasaki K; Kaneda Y; Mu Y; Tsutsumi Y; Nakagawa S; Mayumi T
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1788-92. PubMed ID: 9396155
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene.
Missol-Kolka E; Sochanik A; Szala S
Neoplasma; 1998; 45(5):305-11. PubMed ID: 9921920
[TBL] [Abstract][Full Text] [Related]
10. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure.
Rosso S; Zanetti R; Pippione M; Sancho-Garnier H
Melanoma Res; 1998 Dec; 8(6):573-83. PubMed ID: 9918420
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of 8-Cl-cAMP action.
Juranić Z; Radulović S; Joksimović J; Juranić I
J Exp Clin Cancer Res; 1998 Sep; 17(3):269-75. PubMed ID: 9894761
[TBL] [Abstract][Full Text] [Related]
12. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness.
Holland JC; Kash KM; Passik S; Gronert MK; Sison A; Lederberg M; Russak SM; Baider L; Fox B
Psychooncology; 1998; 7(6):460-9. PubMed ID: 9885087
[TBL] [Abstract][Full Text] [Related]
13. Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism.
Sodi SA; Chakraborty AK; Platt JT; Kolesnikova N; Rosemblat S; Keh-Yen A; Bolognia JL; Rachkovsky ML; Orlow SJ; Pawelek JM
Pigment Cell Res; 1998 Oct; 11(5):299-309. PubMed ID: 9877101
[TBL] [Abstract][Full Text] [Related]
14. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
[TBL] [Abstract][Full Text] [Related]
15. A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work.
Yasumoto K; Amae S; Udono T; Fuse N; Takeda K; Shibahara S
Pigment Cell Res; 1998 Dec; 11(6):329-36. PubMed ID: 9870544
[TBL] [Abstract][Full Text] [Related]
16. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
Mitchell MS
Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
Xia LJ; Han R
Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
[TBL] [Abstract][Full Text] [Related]
18. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
[TBL] [Abstract][Full Text] [Related]
19. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
[TBL] [Abstract][Full Text] [Related]
20. In vitro modulation of proliferation and melanization of melanoma cells by citrate.
Bhatnagar V; Srirangam A; Abburi R
Mol Cell Biochem; 1998 Oct; 187(1-2):57-65. PubMed ID: 9788743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
